Assessment of Peripheral Endothelial-Dependent Vasodilatation Within the First Year After Heart Transplantation

Journal of Heart and Lung Transplantation

Volumn 28, Issue 4, 2009, Pages 299-304

  Roig, Eulalia ^a   Cuppoletti, Alfredo ^a   Masotti, Mónica ^a   Kianco, Ricardo ^a   Vallejos, Isabel ^a   Sitges, Marta ^a   Ortiz, José ^a   Pérez Villa, Félix ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART TRANSPLANTATION; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 62949120129     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.01.002     Document Type: Article

References (41)

1. Elkayam U., Khan S., Mehboob A., and Ahsan N. Impaired endothelium-mediated vasodilatation in heart failure: clinical evidence and the potential for therapy. J Cardiac Fail 8 (2002) 15-20
2. Vita J., Treasure C., Yeung A., et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamine. Circulation 85 (1992) 1390-1397
3. Katz S.D., Schwarz M., Yuen J., and LeJemtel T. Impaired acetylcholine-mediated vasodilatation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88 (1993) 55-61
4. Ferrari R., Bachetti T., Agnoletti L., et al. Endothelial function and dysfunction in heart failure. Eur Heart J 19 suppl G (1998) G41-G47
5. Sitges M., Roig E., Morales M., et al. Impaired endothelium-dependent forearm vasodilatation in idiopathic dilated cardiomyopathy is related to severe left ventricular dysfunction and elevated serum tumor necrosis factor levels. Rev Esp Cardiol 58 (2005) 477-483
6. Sabate M., Cequier A., Manito N., et al. Predictive factors and long-term evolution of early endothelial dysfunction after cardiac transplantation. J Heart Lung Transplant 19 (2000) 453-461
7. Patel A., Kuvin J., Pandian N., et al. Heart failure etiology affects peripheral vascular endothelial function after cardiac transplantation. J Am Coll Cardiol 37 (2001) 195-200
8. Kubo S., Rector T., Bank A., et al. Effects of cardiac transplantation on endothelium-dependent dilation of the peripheral vasculature in congestive heart failure. Am J Cardiol 71 (1993) 88-93
9. Pleiner S., Bayerle-Eder M., Wiesinger G., et al. Regular physical exercise improves endothelial function in heart transplant recipients. Clin Transplant 16 (2002) 137-143
10. Perez-Villa F., Roig E., Ferrer E., et al. Neurohormonal activation in congestive heart failure: does it normalize after heart transplantation?. Rev Esp Cardiol 57 (2004) 725-731
11. Yousufuddin M., Cook D., Starling R., et al. Angiotensin II receptors from peritransplantation through first year post-transplantation and the risk of transplant coronary artery disease. J Am Coll Cardiol 43 (2004) 1565-1573
12. Taylor D., Edwards L., Boucek M., et al. Registry of the international society for heart and lung transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 25 (2006) 869-879
13. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23 (2004) S187-S193
14. Hollenberg S., Klein L., Parrillo J., et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104 (2001) 3091-3096
15. Dong C., Redenbach D., Wood S., Battistini B., Wilson J., and McManus B. The pathogenesis of cardiac allograft vasculopathy. Curr Opin Cardiol 11 (1996) 183-190
16. Mehra M., Uber P., Ventura H., Scott R., and Park M. The impact of mode of donor brain death on cardiac allograft vasculopathy. J Am Coll Cardiol 43 (2004) 806-810
17. Cantin B., Peizhong W., Zhu D., et al. Transplant coronary artery disease. A novel model independent of cellular alloimmnune response. Circulation 104 (2001) 2615-2619
18. Valantine H. The role of viruses in cardiac allograft vasculopathy. Am J Transplant 4 (2003) 169-177
19. Kuvin J., Patel A., Sliney K., et al. Peripheral vascular endothelial function testing as a non-invasive indicator of coronary artery disease. J Am Coll Cardiol 38 (2001) 1843-1849
20. Sitges M., Heras M., Roig E., et al. Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. Eur Heart J 22 (2001) 2116-2124
21. Billingham M.E. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant 1 (1981) 25-30
22. Corretti M., Anderson T., Benjamin E., et al. Guidelines for ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. A report of the international brachial artery reactivity task force. J Am Coll Cardiol 39 (2002) 257-265
23. Pethig K, Heublein B, Meliss RR, Haverich A. Volumetric remodeling of the proximal left coronary artery. Early versus late after heart transplantation. J Am Coll Cardiol 34;1:197-203.
24. Linke A., Schoene N., Gielen S., et al. Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol 37 (2001) 392-397
25. Meyer B., Mörtl D., Strecker K., et al. Flow-mediated vasodilatation predicts outcome in patients with chronic heart failure. Comparison with B-type natriuretic peptide. J Am Coll Cardiol 46 (2005) 1011-1018
26. Fisher D., Rossa S., Landmesser S., et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation or death. Eur Heart J 26 (2005) 65-69
27. El-Hamamsy I., Stevens L., Vanhoutte P., and Perrault L. Injury of coronary endothelium at implantation increases endothelial dysfunction and intimal hyperplasia after heart transplantation. J Heart Lung Transplant 24 (2005) 251-258
28. Holm T., Aukrust P., Andreassen A.K., et al. Peripheral endothelial dysfunction in transplant recipients: possible role of proinflammatoty cytokines. Clin Transplant 14 (2000) 218-225
29. Andreassen A., Gullestad L., Holm T., Simonsen S., and Kvernebo K. Endothelium-dependent vasodilation of the skin microcirculation in heart transplant recipients. Clin Transplant 12 (1998) 324-332
30. Nickel T., Schlichting C., and Weis M. Drugs modulating endothelial function after transplantation. Transplantation 82 (2006) S41-S46
31. Kapadia S., Nissen S., Ziada K., et al. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. J Am Coll Cardiol 38 (2001) 206-213
32. Marin E., and Sessa W. Role of endothelial-derived nitric oxide in hypertension and renal disease. Curr Opin Nephrol Hytens 16 (2007) 105-110
33. Scott D., Gomez C., Golberg C., Crowley D., Rocchini A., and Charpie J. Systemic arterial pressure and brachial arterial flow-mediated dilatation in young cardiac transplant recipients. Am J Cardiol 90 (2002) 1035-1037
34. Okada K., Nishida Y., Murakami H., et al. Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts. Circulation 97 (1998) 2346-2351
35. Utama B., Shen Y., Mitchell B., et al. Mechanisms for human cytomegalovirus-induced cytoplasmatic p53 sequestration in endothelial cells. J Cell Sci 119 (2006) 2457-2467
36. Koskinen P., Nieminen M., Krogerus L., et al. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients. Transpl Int 6 (1993) 341-347
37. Brown B., and Zhao X. Is intravascular ultrasound the gold standard surrogate for clinically relevant atherosclerosis progression?. J Am Coll Cardiol 49 (2007) 933-938
38. Fearon W., Potena L., Hirohata A., et al. Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation 83 (2007) 700-705
39. Ciliberto G., Riffini L., Mangiavacchi M., et al. Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation. Eur Heart J 22 (2001) 964-971
40. Hognestad A., Endresen K., Wergeland R., et al. Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 42 (2003) 477-482
41. Eisen H., Tuzcu M., Dorent R., et al., RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 349 (2003) 847-858